Medigen Biotechnology Corp. (TPEX:3176)
Taiwan
· Delayed Price · Currency is TWD 29.80
-0.35 (-1.16%)
Mar 9, 2026, 1:30 PM CST
Medigen Biotechnology Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 4,151 | 4,514 | 6,243 | 4,685 | 7,999 | 8,228 | Upgrade
|
| Market Cap Growth | -17.68% | -27.70% | 33.24% | -41.43% | -2.78% | -4.46% | Upgrade
|
| Enterprise Value | 5,967 | 6,470 | 8,430 | 7,328 | 10,273 | 10,336 | Upgrade
|
| Last Close Price | 29.80 | 32.40 | 44.80 | 33.60 | 57.40 | 59.20 | Upgrade
|
| PS Ratio | 2.62 | 3.29 | 5.39 | 4.44 | 2.04 | 13.37 | Upgrade
|
| PB Ratio | 0.85 | 0.90 | 1.25 | 0.72 | 1.25 | 1.83 | Upgrade
|
| P/TBV Ratio | 2.69 | 3.05 | 4.20 | 2.25 | 3.52 | 4.96 | Upgrade
|
| P/FCF Ratio | - | - | - | - | 21.32 | - | Upgrade
|
| P/OCF Ratio | 67.95 | 119.03 | - | - | 15.44 | - | Upgrade
|
| EV/Sales Ratio | 3.76 | 4.71 | 7.28 | 6.94 | 2.62 | 16.79 | Upgrade
|
| EV/EBITDA Ratio | 65.88 | - | - | - | 10.62 | - | Upgrade
|
| EV/EBIT Ratio | - | - | - | - | 13.17 | - | Upgrade
|
| EV/FCF Ratio | -535.03 | - | - | - | 27.38 | - | Upgrade
|
| Debt / Equity Ratio | 0.19 | 0.20 | 0.57 | 0.43 | 0.15 | 0.26 | Upgrade
|
| Debt / EBITDA Ratio | 7.71 | - | - | - | 1.02 | - | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | 2.64 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.29 | -0.31 | -0.34 | -0.36 | -0.31 | -0.24 | Upgrade
|
| Net Debt / EBITDA Ratio | -14.94 | 23.68 | 1.60 | 1.58 | -2.07 | 1.52 | Upgrade
|
| Net Debt / FCF Ratio | 129.23 | 92.75 | 3.18 | 1.84 | -5.35 | 1.32 | Upgrade
|
| Asset Turnover | 0.24 | 0.18 | 0.13 | 0.12 | 0.55 | 0.11 | Upgrade
|
| Inventory Turnover | 1.08 | 1.04 | 0.87 | 1.34 | 2.55 | 1.54 | Upgrade
|
| Quick Ratio | 4.07 | 3.20 | 1.81 | 5.32 | 3.60 | 2.72 | Upgrade
|
| Current Ratio | 5.12 | 3.96 | 2.05 | 6.40 | 4.62 | 3.24 | Upgrade
|
| Return on Equity (ROE) | -3.81% | -4.43% | -25.64% | -29.95% | 19.60% | -23.59% | Upgrade
|
| Return on Assets (ROA) | -0.49% | -1.78% | -8.33% | -11.46% | 6.79% | -10.38% | Upgrade
|
| Return on Invested Capital (ROIC) | -1.49% | -6.44% | -33.40% | -39.08% | 18.75% | -26.57% | Upgrade
|
| Return on Capital Employed (ROCE) | -0.90% | -3.80% | -21.50% | -18.70% | 10.90% | -17.50% | Upgrade
|
| Earnings Yield | -2.55% | -4.54% | -8.99% | -14.42% | -0.66% | -4.11% | Upgrade
|
| FCF Yield | -0.27% | -0.38% | -8.68% | -27.46% | 4.69% | -9.97% | Upgrade
|
| Buyback Yield / Dilution | 0.12% | 0.03% | -0.16% | -0.11% | 0.01% | -0.22% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.